Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 45.30
0.00 (0.00%)
At close: Dec 5, 2025
Sagittarius Life Science Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -46.33 | -48.53 | -55.04 | -74.2 | -86.42 | -74.12 | Upgrade |
Depreciation & Amortization | 11.6 | 14.76 | 15.03 | 20.92 | 24.18 | 25.62 | Upgrade |
Other Amortization | - | - | - | - | - | 0.41 | Upgrade |
Loss (Gain) From Sale of Assets | 0.13 | -2.98 | 0.08 | -0.01 | 0.01 | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.75 | - | - | - | - | - | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | 2.98 | - | - | Upgrade |
Other Operating Activities | -2.17 | -3.66 | -3.37 | -3.44 | -1.19 | 0.96 | Upgrade |
Change in Accounts Receivable | 8.6 | -3.52 | -1.25 | 6.29 | 17.37 | -23.56 | Upgrade |
Change in Inventory | 24.41 | 0.49 | -3.6 | 0.63 | 4.31 | -9.56 | Upgrade |
Change in Accounts Payable | -29.66 | -3.97 | -13.36 | -5.23 | 24.81 | 7.73 | Upgrade |
Change in Other Net Operating Assets | 8.87 | 2.94 | -7.87 | -0.83 | -12.25 | 10.28 | Upgrade |
Operating Cash Flow | -25.32 | -44.48 | -69.37 | -52.89 | -29.18 | -62.24 | Upgrade |
Capital Expenditures | -0.39 | -3.29 | -2.01 | -1.09 | -8.22 | -10.89 | Upgrade |
Sale of Property, Plant & Equipment | 3.7 | - | - | 0.06 | 0.09 | - | Upgrade |
Divestitures | 1.4 | - | - | 2 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -0.1 | -0.51 | - | - | -0.21 | -0.31 | Upgrade |
Investment in Securities | -584.49 | 3.08 | 20.96 | -3.57 | -97.1 | -30.59 | Upgrade |
Other Investing Activities | 3.76 | 3.45 | 1.5 | 1.46 | 0.63 | -0.32 | Upgrade |
Investing Cash Flow | -576.12 | 2.73 | 20.45 | -1.14 | -104.82 | -42.11 | Upgrade |
Long-Term Debt Repaid | - | -9.33 | -8.4 | -12.44 | -16.1 | -16.87 | Upgrade |
Total Debt Repaid | -6.09 | -9.33 | -8.4 | -12.44 | -16.1 | -16.87 | Upgrade |
Net Debt Issued (Repaid) | -6.09 | -9.33 | -8.4 | -12.44 | -16.1 | -16.87 | Upgrade |
Issuance of Common Stock | 677.56 | - | - | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | - | - | - | -8.74 | Upgrade |
Other Financing Activities | -10.03 | -0.56 | 2.5 | -0.72 | 11.94 | 2.17 | Upgrade |
Financing Cash Flow | 661.44 | -9.89 | -5.9 | -13.16 | -4.16 | -23.44 | Upgrade |
Foreign Exchange Rate Adjustments | -1.88 | 1.53 | -0.77 | 1.01 | -0.42 | -0.5 | Upgrade |
Net Cash Flow | 58.12 | -50.1 | -55.59 | -66.18 | -138.58 | -128.29 | Upgrade |
Free Cash Flow | -25.71 | -47.77 | -71.38 | -53.98 | -37.4 | -73.13 | Upgrade |
Free Cash Flow Margin | -6.06% | -10.21% | -16.21% | -10.20% | -6.37% | -13.10% | Upgrade |
Free Cash Flow Per Share | -0.57 | -1.47 | -2.19 | -1.66 | -1.15 | -2.24 | Upgrade |
Cash Interest Paid | 0.12 | 0.21 | 0.08 | 0.23 | 0.39 | 0.33 | Upgrade |
Cash Income Tax Paid | 0.16 | 0.08 | -0.11 | -0.18 | 0.18 | -0.72 | Upgrade |
Levered Free Cash Flow | -9.56 | -34.74 | -28.2 | -50.35 | -15.51 | -54.72 | Upgrade |
Unlevered Free Cash Flow | -9.48 | -34.61 | -28.15 | -50.2 | -15.27 | -54.51 | Upgrade |
Change in Working Capital | 12.21 | -4.06 | -26.07 | 0.86 | 34.24 | -15.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.